March 26, 2020 / 12:06 PM / 10 days ago

BRIEF-Unum Therapeutics Reports Q4 Loss Per Share $0.07

March 26 (Reuters) - Unum Therapeutics Inc:

* UNUM THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES

* Q4 LOSS PER SHARE $0.07

* Q4 EARNINGS PER SHARE ESTIMATE $-0.29 — REFINITIV IBES DATA

* HAS INITIATED A PROCESS TO EXPLORE STRATEGIC ALTERNATIVES

* UNUM THERAPEUTICS - POTENTIAL STRATEGIC ALTERNATIVES THAT MAY BE EVALUATED INCLUDE, BUT ARE NOT LIMITED TO, ACQUISITION, MERGER, BUSINESS COMBINATION

* UNUM THERAPEUTICS- POTENTIAL STRATEGIC ALTERNATIVES THAT MAY BE EVALUATED INCLUDE, BUT ARE NOT LIMITED TO, IN-LICENSING, OTHER STRATEGIC TRANSACTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below